SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-029720
Filing Date
2019-05-14
Accepted
2019-05-14 17:26:05
Documents
1
Period of Report
2019-05-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4096
  Complete submission text file 0001209191-19-029720.txt   5768
Mailing Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Issuer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 385 OYSTER POINT BLVD., SUITE 9A SOUTH SAN FRANCISCO CA 94080
Business Address
Latour Wouter (Reporting) CIK: 0001652203 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35285 | Film No.: 19824004